watch cbsn live by aimee picchi updated on april 17 2020 4 22 pm moneywatch u s stocks rallied on friday with investors buoyed by a promising early report about gilead sciences experimental drug remdesivir s impact on covid 19 patients wall street is also optimistic that parts of the economy could start to reopen soon the dow rose 705 points or 3 to 24 242 while the broad based s p 500 stock index rose 2 7 and the tech heavy nasdaq composite 1 4 gilead sciences shares jumped 9 7 after a clinical trial of remdesivir on severe covid 19 patients reportedly resulted in quick recoveries from the disease s symptoms almost all the patients in the study were discharged in less than a week according to the report in medical business publication stat investors are also optimistic about portions of the u s economy reopening for business after president donald trump released guidelinesfor getting people back to work that favored local governors decisions over any federal mandate in a week of negative economic headlines it s certainly encouraging to end on a more positive note and equity markets are surging this morning as a result craig erlam senior market analyst at oanda europe wrote in a client note the double whammy of u s lockdown exit plans and more importantly a potential coronavirus treatment from gilead has given investors cause for optimism heading into the weekend the white house plan called opening up america again is expected to put much of the onus on states to developsufficient testingandcontact tracingsystems it also lists basic gating criteria a state or region should reach before beginning to send people back to work and school mr trump relayed the guidelines on a thursday afternoon call at his daily press briefing thursday evening mr trump said we re starting our life again we re starting rejuvenation of our economy again adding that this is a gradual process even so much of the u s remains on lockdown and more than 22 million americans or 1 in 7 workers have lost their jobs in the last month alone economic data for march indicates an earlier and larger hit to activity than we had anticipated oxford economics said in a friday report retail sales and industrial production data points to a severe collapse in spending and output in the final two weeks of march the gilead trial of its remdesivir drug involved 125 people with covid 19 through the university of chicago medicine all of them were treated with daily infusions of the drug and most of the patients were discharged from the hospital stat reported citing comments from kathleen mullane the university of chicago infectious disease specialist who is overseeing the study she said that two patients died to be sure the results are still early and are part of a larger study of patients at other institutions with gilead yet to release full results in a statement to stat gilead said what we can say at this stage is that we look forward to data from ongoing studies becoming available gilead known for its hiv prevention drugs has also been the focus of accusations of price gouging among other issues the trump administration last year sued gilead for earning billions from research backed by taxpayer funding without paying back the the support as well as infringing on patents owned by the u s department of health and human services first published on april 17 2020 10 27 am 2020 cbs interactive inc all rights reserved be in the know get the latest breaking news delivered straight to your inbox copyright 2020 cbs interactive inc all rights reserved quotes delayed at least 15 minutes market data provided by ice data services ice limitations powered and implemented by factset news provided by the associated press legal statement 